{
    "nctId": "NCT02557906",
    "briefTitle": "Evaluating Outcomes of Immediate Breast Reconstruction (POBRAD-M)",
    "officialTitle": "Prospective, Multi-centre, Observational Trial Evaluating Outcomes of Immediate Breast Reconstruction Using an Implant and Acellular Dermal Matrix (SurgiMend) or Autologous Tissue",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Neoplasms, Breast Diseases",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 209,
    "primaryOutcomeMeasure": "Number of patients with adverse events",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Informed consent given\n* Unilateral or bilateral mastectomy (therapeutic, contra lateral or prophylactic)\n* Immediate reconstruction;\n* Suitable for immediate implant reconstruction with ADM\n\nExclusion Criteria:\n\n* Patients unable to provide informed consent to participate in trial\n* Patients unavailable for follow-up\n* Not eligible for immediate breast reconstruction using an ADM",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}